Huh WK, Brady WE, Fracasso PM, Dizon DS, et al. Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study. Gynecol Oncol 2020 Jul 5. pii: S0090-8258(20)32317.
PMID: 32641240